# Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis

> **NCT05246267** · — · RECRUITING · sponsor: **Montefiore Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **BIOLOGICAL:** Dupilumab

## Key facts

- **NCT ID:** NCT05246267
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-15
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05246267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05246267, "Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05246267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*